Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy Followed by TORS in Oropharyngeal Cancer
NCT02760667Phase 2Unknown
- Sponsor
- George Washington University
- Start
- Jun 2015
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, docetaxel in oropharyngeal squamous cell carcinoma (OPSCC), laryngeal squamous cell carcinoma (LSCC), sponsored by George Washington University. Status: unknown.
02
Drugs
cisplatindocetaxel
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)laryngeal squamous cell carcinoma (LSCC)
Beyond the preview
Go deeper on NCT02760667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760667.